34 results
351 |
Clinical Circulating Tumor DNA Testing for Precision Oncology
Hyunji Kim, Kyoung Un Park
KMSID: 1516082480 Cancer Res Treat. 2023;55(2):351-366. Published online 2023 March 13 DOI: http://dx.doi.org/10.4143/crt.2022.1026 | |
367 |
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Yongjun Cha, Sheehyun Kim, Sae-Won Han
KMSID: 1516082509 Cancer Res Treat. 2023;55(2):367-384. 2023 April DOI: http://dx.doi.org/10.4143/crt.2023.446 | |
385 |
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020
Mee Joo Kang, Kyu-Won Jung, So Hyun Bang, Seo Hyun Choi, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
KMSID: 1516082511 Cancer Res Treat. 2023;55(2):385-399. 2023 April DOI: http://dx.doi.org/10.4143/crt.2023.447 | |
400 |
Prediction of Cancer Incidence and Mortality in Korea, 2023
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
KMSID: 1516082510 Cancer Res Treat. 2023;55(2):400-407. 2023 April DOI: http://dx.doi.org/10.4143/crt.2023.448 | |
408 |
Trends and Patterns of Cancer Burdens by Region and Income Level in Korea: A National Representative Big Data Analysis
Yoon-Sun Jung, Seok-Jun Yoon
KMSID: 1516082483 Cancer Res Treat. 2023;55(2):408-418. Published online 2022 September 6 DOI: http://dx.doi.org/10.4143/crt.2022.126 | |
419 |
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients’ Returning to Work (START): A Multi-center, Randomized Controlled Trial
Danbee Kang, Ka Ryeong Bae, Yeojin Ahn, Nayeon Kim, Seok Jin Nam, Jeong Eon Lee, Se Kyung Lee, Young Mog Shim, Dong Hyun Sinn, Seung Yeop Oh, Mison Chun, Jaesung Heo, Juhee Cho
KMSID: 1516082506 Cancer Res Treat. 2023;55(2):419-428. Published online 2022 November 8 DOI: http://dx.doi.org/10.4143/crt.2022.939 | |
429 |
Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors
Moonsik Kim, Changseon Lee, Juyeon Hong, Juhee Kim, Ji Yun Jeong, Nora Jee-Young Park, Ji-Eun Kim, Ji Young Park
KMSID: 1516082502 Cancer Res Treat. 2022;55(2):429-441. Published online 2022 November 25 DOI: http://dx.doi.org/10.4143/crt.2022.891 | |
442 |
Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20)
Jung Sun Kim, Jung Hye Kwon, Sun Young Rha, Sang-Cheol Lee, Yoon Jung Chang, In-Sun Kwon, Kyung Han You, Ho Young Yoon
KMSID: 1516082488 Cancer Res Treat. 2023;55(2):442-451. 2023 April DOI: http://dx.doi.org/10.4143/crt.2022.1483 | |
452 |
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma
Mi-Sook Lee, Sungbin An, Ji-Young Song, Minjung Sung, Kyungsoo Jung, Eun Sol Chang, Juyoung Choi, Doo-Yi Oh, Yoon Kyung Jeon, Hobin Yang, Chaithanya Lakshmi, Sehhoon Park, Joungho Han, Se-Hoon Lee, Yoon-La Choi
KMSID: 1516082505 Cancer Res Treat. 2022;55(2):452-467. Published online 2022 October 14 DOI: http://dx.doi.org/10.4143/crt.2022.910 | |
468 |
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
Yoon Jung Jang, Dong-gon Hyun, Wonjun Ji, Chang-Min Choi, Shinkyo Yoon, Dae Ho Lee, Sang-We Kim, Jae Cheol Lee
KMSID: 1516082482 Cancer Res Treat. 2022;55(2):468-478. Published online 2022 November 28 DOI: http://dx.doi.org/10.4143/crt.2022.1342 | |
479 |
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non–Small Cell Lung Cancer
Hyun Ae Jung, Sehhoon Park, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Jong-Mu Sun
KMSID: 1516082485 Cancer Res Treat. 2022;55(2):479-487. Published online 2022 December 27 DOI: http://dx.doi.org/10.4143/crt.2022.1344 | |
488 |
Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing
Beung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
KMSID: 1516082495 Cancer Res Treat. 2023;55(2):488-497. Published online 2022 November 9 DOI: http://dx.doi.org/10.4143/crt.2022.359 | |
498 |
EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
Hongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
KMSID: 1516082496 Cancer Res Treat. 2023;55(2):498-505. Published online 2022 October 4 DOI: http://dx.doi.org/10.4143/crt.2022.388 | |
506 |
The Additive Impact of Transbronchial Cryobiopsy Using a 1.1-mm Diameter Cryoprobe on Conventional Biopsy for Peripheral Lung Nodules
Soo Han Kim, Jeongha Mok, Eun-Jung Jo, Mi-Hyun Kim, Kwangha Lee, Ki Uk Kim, Hye-Kyung Park, Min Ki Lee, Jung Seop Eom
KMSID: 1516082481 Cancer Res Treat. 2022;55(2):506-512. Published online 2022 November 1 DOI: http://dx.doi.org/10.4143/crt.2022.1008 | |
513 |
Diagnostic Assessment of Deep Learning Algorithms for Frozen Tissue Section Analysis in Women with Breast Cancer
Young-Gon Kim, In Hye Song, Seung Yeon Cho, Sungchul Kim, Milim Kim, Soomin Ahn, Hyunna Lee, Dong Hyun Yang, Namkug Kim, Sungwan Kim, Taewoo Kim, Daeyoung Kim, Jonghyeon Choi, Ki-Sun Lee, Minuk Ma, Minki Jo, So Yeon Park, Gyungyub Gong
KMSID: 1516082479 Cancer Res Treat. 2023;55(2):513-522. Published online 2022 September 6 DOI: http://dx.doi.org/10.4143/crt.2022.055 | |
523 |
A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)
Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, Jin-Hee Ahn, Joohyuk Sohn, Jin Seok Ahn, Moon Hee Lee, Jee Hyun Kim, Kyung Eun Lee, Hyo Jung Kim, Si-Young Kim, Yeon Hee Park, Chan-Young Ock, Kyung-Hun Lee, Sae-Won Han, Sung-Bae Kim, Young Hyuck Im, Hyun Cheol Chung, Do-Youn Oh, Seock-Ah Im
KMSID: 1516082484 Cancer Res Treat. 2023;55(2):523-530. Published online 2022 November 8 DOI: http://dx.doi.org/10.4143/crt.2022.1360 | |
531 |
PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
Ju Won Kim, Ah Reum Lim, Ji Young You, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park
KMSID: 1516082491 Cancer Res Treat. 2023;55(2):531-541. Published online 2022 September 7 DOI: http://dx.doi.org/10.4143/crt.2022.221 | |
542 |
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy
Eun-Gyeong Lee, Dong-Eun Lee, Hyun Hee Kim, Jai Hong Han, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Heejung Chae, Sung Hoon Sim, Keun Seok Lee, Youngmee Kwon, So-Youn Jung
KMSID: 1516082498 Cancer Res Treat. 2023;55(2):542-550. Published online 2022 September 8 DOI: http://dx.doi.org/10.4143/crt.2022.834 | |
551 |
Marked Reduction in the Risk of Dementia in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study
Jooyoung Oh, Hye Sun Lee, Soyoung Jeon, Jeong-Ho Seok, Tae-Kyung Yoo, Woo-Chan Park, Chang Ik Yoon
KMSID: 1516082492 Cancer Res Treat. 2023;55(2):551-561. Published online 2022 October 19 DOI: http://dx.doi.org/10.4143/crt.2022.272 | |
562 |
Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis
Changjin Lim, Eunhye Kang, Ji Gwang Jung, Jong-Ho Cheun, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han
KMSID: 1516082500 Cancer Res Treat. 2023;55(2):562-569. Published online 2022 September 26 DOI: http://dx.doi.org/10.4143/crt.2022.871 | |
570 |
Quality Assessment and Trend for Breast Cancer Treatment Practice across South Korea Based on Nationwide Analysis of Korean Health Insurance Data during 2013–2017
Kyu Hye Choi, Soo-Yoon Sung, Sea-Won Lee, Ye Won Jeon, Sung Hwan Kim, Jong Hoon Lee
KMSID: 1516082501 Cancer Res Treat. 2023;55(2):570-579. Published online 2022 December 5 DOI: http://dx.doi.org/10.4143/crt.2022.882 | |
580 |
Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population–Based Study by the SMARTSHIP Group
Haeyoung Kim, Su SSan Kim, Ji Sung Lee, Jae Sun Yoon, Hyun Jo Youn, Hyukjai Shin, Jeong Eon Lee, Se Kyung Lee, Il Yong Chung, So-Youn Jung, Young Jin Choi, Jihyoung Cho, Sang Uk Woo
KMSID: 1516082497 Cancer Res Treat. 2023;55(2):580-591. Published online 2022 December 27 DOI: http://dx.doi.org/10.4143/crt.2022.410 | |
592 |
Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy
Dowook Kim, Jin Ho Kim, In Ah Kim, Ji Hyun Chang, Kyung Hwan Shin
KMSID: 1516082508 Cancer Res Treat. 2023;55(2):592-602. Published online 2022 October 11 DOI: http://dx.doi.org/10.4143/crt.2022.998 | |
603 |
Descriptive Analysis of Gastric Cancer Mortality in Korea, 2000–2020
Tung Hoang, Hyeongtaek Woo, Sooyoung Cho, Jeeyoo Lee, Sayada Zartasha Kazmi, Aesun Shin
KMSID: 1516082493 Cancer Res Treat. 2023;55(2):603-617. Published online 2022 September 6 DOI: http://dx.doi.org/10.4143/crt.2022.307 | |
618 |
Colonoscopic Screening and Risk of All-Cause and Colorectal Cancer Mortality in Young and Older Individuals
Jung Ah Lee, Yoosoo Chang, Yejin Kim, Dong-Il Park, Soo-Kyung Park, Hye Yin Park, Jaewoo Koh, Soo-Jin Lee, Seungho Ryu
KMSID: 1516082499 Cancer Res Treat. 2023;55(2):618-625. Published online 2022 September 19 DOI: http://dx.doi.org/10.4143/crt.2022.852 | |
626 |
Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis
Ting Xu, Xicheng Wang, Ying Xin, Zhenghang Wang, Jifang Gong, Xiaotian Zhang, Yanyan Li, Congcong Ji, Yu Sun, Feilong Zhao, Depei Huang, Yuezong Bai, Jian Li, Lin Shen
KMSID: 1516082478 Cancer Res Treat. 2023;55(2):626-635. Published online 2022 December 23 DOI: http://dx.doi.org/10.4143/crt.2022.1058 | |
636 |
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park
KMSID: 1516082494 Cancer Res Treat. 2023;55(2):636-642. Published online 2022 October 6 DOI: http://dx.doi.org/10.4143/crt.2022.343 | |
643 |
Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy
Sang Joon Shin, Jae Lyun Lee, Tae Gyun Kwon, Byoung Young Shim, Ho Seok Chung, Sang-Hee Kim, Se Hoon Park
KMSID: 1516082503 Cancer Res Treat. 2023;55(2):643-651. Published online 2022 November 28 DOI: http://dx.doi.org/10.4143/crt.2022.883 | |
652 |
A Nationwide Study of Differences in Surgical Treatment Rates and Oncological Outcomes for Prostate Cancer according to Economic Status and Region
Sangjun Yoo, Sohee Oh, Min Chul Cho, Hwancheol Son, Hyeon Jeong
KMSID: 1516082504 Cancer Res Treat. 2023;55(2):652-658. Published online 2022 December 12 DOI: http://dx.doi.org/10.4143/crt.2022.893 | |
659 |
Plasma Cell-Free DNA in Uterine Cervical Cancer: Therapeutic Monitoring and Prognostic Values after Radical Radiotherapy
Jae Sik Kim, Sunah Yang, Kyeonghun Jeong, Dong-Yun Kim, Kwangsoo Kim, Hyun-Cheol Kang
KMSID: 1516082487 Cancer Res Treat. 2023;55(2):659-670. Published online 2022 December 12 DOI: http://dx.doi.org/10.4143/crt.2022.1440 | |
671 |
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response
Jung Yong Hong, Hee Jin Cho, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Sang Kyum Kim, Yurimi Lee, Yoon-La Choi, Minsuk Kwon, Hyo Song Kim, Jeeyun Lee
KMSID: 1516082490 Cancer Res Treat. 2023;55(2):671-683. Published online 2022 September 27 DOI: http://dx.doi.org/10.4143/crt.2022.251 | |
684 |
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Seok Jin Kim, Young Rok Do, Gyeong-Won Lee, Jae-Yong Kwak, Yong Park, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Kwai Han Yoo, Won Sik Lee, Byeong Bae Park, Jae Cheol Jo, Hyeon-Seok Eom, Hyo Jung Kim, Seong Hyun Jeong, Young-Woong Won, Byeong Seok Sohn, Ji-Hyun Kwon, Cheolwon Suh, Won Seog Kim
KMSID: 1516082486 Cancer Res Treat. 2023;55(2):684-692. Published online 2023 January 2 DOI: http://dx.doi.org/10.4143/crt.2022.1434 | |
693 |
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study
Jongheon Jung, Kihyun Kim, Sung-Hoon Jung, Sung-Soo Yoon, Jae Hoon Lee, Jin Seok Kim, Ho-Jin Shin, Soo-Mee Bang, Sang Kyun Sohn, Cheolwon Suh, Dok Hyun Yoon, Sun-Young Kong, Chang-Ki Min, Hyeon-Seok Eom
KMSID: 1516082507 Cancer Res Treat. 2023;55(2):693-703. Published online 2022 November 16 DOI: http://dx.doi.org/10.4143/crt.2022.952 | |
704 |
Hepatitis B Virus Reactivation in a Chronic Lymphocytic Leukemia Patient Treated with Ibrutinib
Jung Hye Choi, Joon Young Hur, Young-Woong Won
KMSID: 1516082489 Cancer Res Treat. 2023;55(2):704-705. Published online 2023 January 16 DOI: http://dx.doi.org/10.4143/crt.2022.1524 | |